Brief: Ikena Oncology Inc Says On June 30, Got Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq
June 30 (Reuters) - Ikena Oncology Inc IKNA.O :
* IKENA ONCOLOGY INC- ON JUNE 30, GOT NOTICE OF DELISTING OR
FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD FROM
NASDAQ
Source text for Eikon: ID:
Further company coverage: IKNA.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on ImageneBio
See all newsU.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune
U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma
Brief: ImageneBio Inc - On Oct 23, Elects Not To Renew Agreement With Miragene - SEC Filing
ImageneBio Inc expected to post a loss of $1.56 a share - Earnings Preview
Brief: Ikena Oncology Announces Stockholder Approval Of Merger With Inmagene Biopharmaceuticals